Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system

J. Neurochem. (2011) 118, 680–694.

[1]  Juliette van Steenwinckel,et al.  CCL2 Released from Neuronal Synaptic Vesicles in the Spinal Cord Is a Major Mediator of Local Inflammation and Pain after Peripheral Nerve Injury , 2011, The Journal of Neuroscience.

[2]  A. Członkowska,et al.  Inflammation and gliosis in neurological diseases – clinical implications , 2011, Journal of Neuroimmunology.

[3]  L. Kular,et al.  Chemokines and chemokine receptors: New actors in neuroendocrine regulations , 2011, Frontiers in Neuroendocrinology.

[4]  O. Marín,et al.  Cxcr7 Controls Neuronal Migration by Regulating Chemokine Responsiveness , 2011, Neuron.

[5]  Toshiharu Yamamoto,et al.  Immunohistochemical localization of chemokine CXCL14 in rat hypothalamic neurons , 2011, Neuroscience Letters.

[6]  R. Ransohoff,et al.  Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice , 2010, PloS one.

[7]  F. D’Acquisto,et al.  Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice , 2010, Journal of neurochemistry.

[8]  G. Conductier,et al.  The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases , 2010, Journal of Neuroimmunology.

[9]  B. Fredholm,et al.  CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes , 2010, Journal of Neuroimmunology.

[10]  M. Prinz,et al.  Tickets to the brain: Role of CCR2 and CX3CR1 in myeloid cell entry in the CNS , 2010, Journal of Neuroimmunology.

[11]  C. Limatola,et al.  CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity. , 2010, American journal of physiology. Cell physiology.

[12]  C. Hunter,et al.  Trafficking of immune cells in the central nervous system. , 2010, The Journal of clinical investigation.

[13]  J. Eisenach,et al.  Contribution of the Chemokine (C-C Motif) Ligand 2 (CCL2) to Mechanical Hypersensitivity after Surgical Incision in Rats , 2010, Anesthesiology.

[14]  T. Kossmann,et al.  Role of Chemokines in CNS Health and Pathology: A Focus on the CCL2/CCR2 and CXCL8/CXCR2 Networks , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[15]  A. Serrano,et al.  Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain , 2010, Molecular pain.

[16]  R. Ransohoff.  Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. , 2009, Immunity.

[17]  W. Rostène,et al.  Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release , 2009, Neuroscience.

[18]  P. Grammas,et al.  RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons , 2009, Neuropeptides.

[19]  B. Melchior,et al.  Differential gene expression in LPS/IFNγ activated microglia and macrophages: in vitro versus in vivo , 2009, Journal of neurochemistry.

[20]  Zhen-Zhong Xu,et al.  JNK-Induced MCP-1 Production in Spinal Cord Astrocytes Contributes to Central Sensitization and Neuropathic Pain , 2009, The Journal of Neuroscience.

[21]  John Grist,et al.  CCL2 is a key mediator of microglia activation in neuropathic pain states , 2009, European journal of pain.

[22]  Richard J. Miller,et al.  Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy , 2009, Molecular pain.

[23]  E. Hirsch,et al.  Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. , 2008, The Journal of clinical investigation.

[24]  H. Boddeke,et al.  The FASEB Journal • Research Communication Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles , 2022 .

[25]  W. Rostène,et al.  Chemokine Action in the Nervous System , 2008, The Journal of Neuroscience.

[26]  G. Bonvento,et al.  Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy , 2008, Molecular Neurobiology.

[27]  S. Schulz,et al.  Regional and cellular localization of the CXCl12/SDF‐1 chemokine receptor CXCR7 in the developing and adult rat brain , 2008, The Journal of comparative neurology.

[28]  S. Carmichael,et al.  Poststroke Neurogenesis: Emerging Principles of Migration and Localization of Immature Neurons , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[29]  Richard J. Miller,et al.  CXCR4 signaling in the regulation of stem cell migration and development , 2008, Journal of Neuroimmunology.

[30]  G. Constantin.  Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain , 2008, Journal of Neuroimmunology.

[31]  W. Rostène,et al.  Chemokines and neuromodulation , 2008, Journal of Neuroimmunology.

[32]  W. Rostène,et al.  Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist‐treated rats , 2008, Journal of neurochemistry.

[33]  Hosung Jung,et al.  The Chemokine Stromal Cell-Derived Factor-1 Regulates GABAergic Inputs to Neural Progenitors in the Postnatal Dentate Gyrus , 2008, The Journal of Neuroscience.

[34]  S. Miller,et al.  Astrocytes in multiple sclerosis: A product of their environment , 2008, Cellular and Molecular Life Sciences.

[35]  R. Ransohoff,et al.  Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation , 2008, Journal of leukocyte biology.

[36]  R. Ransohoff,et al.  Multiple roles of chemokine CXCL12 in the central nervous system: A migration from immunology to neurobiology , 2008, Progress in Neurobiology.

[37]  M. Mattson.  Hormesis defined , 2008, Ageing Research Reviews.

[38]  Hosung Jung,et al.  Chemokines and the pathophysiology of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[39]  R. Ransohoff,et al.  Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses , 2007, Neuroscience.

[40]  Y. de Koninck,et al.  Expression of CCR2 in Both Resident and Bone Marrow-Derived Microglia Plays a Critical Role in Neuropathic Pain , 2007, The Journal of Neuroscience.

[41]  W. Rostène,et al.  Chemokines: a new class of neuromodulator? , 2007, Nature Reviews Neuroscience.

[42]  H. Neumann,et al.  Neuronal ‘On’ and ‘Off’ signals control microglia , 2007, Trends in Neurosciences.

[43]  Andrew R Segerdahl,et al.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.

[44]  A. Beitz,et al.  Chemical Interactions between Fibrosarcoma Cancer Cells and Sensory Neurons Contribute to Cancer Pain , 2007, The Journal of Neuroscience.

[45]  Hosung Jung,et al.  Monocyte chemoattractant protein‐1 functions as a neuromodulator in dorsal root ganglia neurons , 2007, Journal of neurochemistry.

[46]  S. Waxman,et al.  Modulation of Thalamic Nociceptive Processing after Spinal Cord Injury through Remote Activation of Thalamic Microglia by Cysteine–Cysteine Chemokine Ligand 21 , 2007, The Journal of Neuroscience.

[47]  W. Rostène,et al.  The chemokine stromal cell‐derived factor‐1/CXCL12 activates the nigrostriatal dopamine system , 2007, Journal of neurochemistry.

[48]  M. Chopp,et al.  Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke , 2007, Journal of neuroscience research.

[49]  H. Boddeke,et al.  Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction , 2007, Molecular Neurobiology.

[50]  R. Dempsey,et al.  Monocyte Chemoattractant Protein-1 Plays a Critical Role in Neuroblast Migration after Focal Cerebral Ischemia , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[51]  P S Whitton,et al.  Inflammation as a causative factor in the aetiology of Parkinson's disease , 2007, British journal of pharmacology.

[52]  J. Nahon,et al.  Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. , 2007, Journal of molecular endocrinology.

[53]  S. Carmichael,et al.  A Neurovascular Niche for Neurogenesis after Stroke , 2006, The Journal of Neuroscience.

[54]  R. LaMotte,et al.  MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. , 2006, Journal of neurophysiology.

[55]  R. Ransohoff,et al.  CC Chemokine Receptor 2 is Protective Against Noise-Induced Hair Cell Death: Studies in CX3CR1+/GFP Mice , 2006, Journal of the Association for Research in Otolaryngology.

[56]  W. Rostène,et al.  The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Y. Koninck,et al.  Spatial and temporal relationship between monocyte chemoattractant protein‐1 expression and spinal glial activation following peripheral nerve injury , 2006, Journal of neurochemistry.

[58]  Richard J. Miller,et al.  Chemokines Regulate the Migration of Neural Progenitors to Sites of Neuroinflammation , 2006, The Journal of Neuroscience.

[59]  W. Rostène,et al.  Stromal cell‐derived factor‐1α modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms , 2006, Journal of neurochemistry.

[60]  J. Huber,et al.  Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. , 2006, American journal of physiology. Heart and circulatory physiology.

[61]  N. Rothwell,et al.  The role of inflammation in CNS injury and disease , 2006, British journal of pharmacology.

[62]  S. Maier,et al.  An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine , 2005, The European journal of neuroscience.

[63]  W. Rostène,et al.  Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: Functional effect of MCP‐1/CCL2 on calcium mobilization in primary cultured neurons , 2005, The Journal of comparative neurology.

[64]  W. Rostène,et al.  Constitutive expression of CCR2 chemokine receptor and inhibition by MCP‐1/CCL2 of GABA‐induced currents in spinal cord neurones , 2005, Journal of neurochemistry.

[65]  Richard J. Miller,et al.  Chemokines: Integrators of Pain and Inflammation , 2005, Nature Reviews Drug Discovery.

[66]  Xian Wang,et al.  CCL2 and CXCL1 trigger calcitonin gene‐related peptide release by exciting primary nociceptive neurons , 2005, Journal of neuroscience research.

[67]  R. LaMotte,et al.  Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T. Jessell,et al.  A Cxcl12-Cxcr4 Chemokine Signaling Pathway Defines the Initial Trajectory of Mammalian Motor Axons , 2005, Neuron.

[69]  W. Rostène,et al.  Highly regionalized neuronal expression of monocyte chemoattractant protein‐1 (MCP‐1/CCL2) in rat brain: Evidence for its colocalization with neurotransmitters and neuropeptides , 2005, The Journal of comparative neurology.

[70]  H. Boddeke,et al.  Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion , 2005, The Journal of Neuroscience.

[71]  N. Jochnowitz,et al.  Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. , 2005, The journal of pain : official journal of the American Pain Society.

[72]  E. Grove,et al.  The Chemokine Stromal Cell-Derived Factor-1 Regulates the Migration of Sensory Neuron Progenitors , 2005, The Journal of Neuroscience.

[73]  Stephen B. McMahon,et al.  Immune and glial cell factors as pain mediators and modulators , 2005, Experimental Neurology.

[74]  P. Kitabgi,et al.  The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons , 2005, Journal of Cell Science.

[75]  S. Maier,et al.  Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats , 2004, The European journal of neuroscience.

[76]  K. Felszeghy,et al.  Dexamethasone Downregulates Chemokine Receptor CXCR4 and Exerts Neuroprotection against Hypoxia/Ischemia-Induced Brain Injury in Neonatal Rats , 2004, Neuroimmunomodulation.

[77]  I. Bechmann,et al.  CXCR3-Dependent Microglial Recruitment Is Essential for Dendrite Loss after Brain Lesion , 2004, The Journal of Neuroscience.

[78]  S. Maier,et al.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions , 2004, The European journal of neuroscience.

[79]  T. Nakagawa,et al.  Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain , 2004, Neuroscience Research.

[80]  Andre Parent,et al.  Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration , 2003, Annals of neurology.

[81]  W. Rostène,et al.  Highly regionalized distribution of stromal cell‐derived factor‐1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons , 2003, The European journal of neuroscience.

[82]  S. Schulz,et al.  CXCR4 Regulates Interneuron Migration in the Developing Neocortex , 2003, The Journal of Neuroscience.

[83]  J. Mudgett,et al.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Richard J. Miller,et al.  Chemokine receptors: signposts to brain development and disease , 2003, Nature Reviews Neuroscience.

[85]  C. Yiannoutsos,et al.  SDF‐1α Is Expressed in Astrocytes and Neurons in the AIDS Dementia Complex: An In Vivo and In Vitro Study , 2003 .

[86]  W. Rostène,et al.  Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons , 2002, The European journal of neuroscience.

[87]  D. Kolson,et al.  Chemokine receptors in the brain: their role in HIV infection and pathogenesis. , 2002, AIDS.

[88]  F. Eusebi,et al.  Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cells , 2002, Journal of Neuroimmunology.

[89]  C. Culmsee,et al.  A Dual Role for the SDF-1/CXCR4 Chemokine Receptor System in Adult Brain: Isoform-Selective Regulation of SDF-1 Expression Modulates CXCR4-Dependent Neuronal Plasticity and Cerebral Leukocyte Recruitment after Focal Ischemia , 2002, The Journal of Neuroscience.

[90]  F. Eusebi,et al.  Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum , 2002, Journal of Neuroimmunology.

[91]  H. Kettenmann,et al.  Secondary Lymphoid Tissue Chemokine (CCL21) Activates CXCR3 to Trigger a Cl− Current and Chemotaxis in Murine Microglia1 , 2002, The Journal of Immunology.

[92]  C. Overall,et al.  Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* , 2001, The Journal of Biological Chemistry.

[93]  R J Miller,et al.  Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.

[94]  G. Kollias,et al.  CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity , 2001, Nature Neuroscience.

[95]  A. Sauter,et al.  Ischemia‐induced neuronal expression of the microglia attracting chemokine secondary lymphoid‐tissue chemokine (SLC) , 2001, Glia.

[96]  W. Rostène,et al.  Characterization and visualization of [125I] stromal cell-derived factor-1α binding to CXCR4 receptors in rat brain and human neuroblastoma cells , 2000, Journal of Neuroimmunology.

[97]  R. Doms,et al.  Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons , 2000, Neuroscience.

[98]  P. Piccioli,et al.  Glial and Neuronal Cells Express Functional Chemokine Receptor CXCR4 and Its Natural Ligand Stromal Cell‐Derived Factor 1 , 1999, Journal of neurochemistry.

[99]  O. Meucci,et al.  AIDS and the brain: is there a chemokine connection? , 1999, Trends in Neurosciences.

[100]  Jialin Zheng,et al.  Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia , 1999, Journal of Neuroimmunology.

[101]  M. Kaul,et al.  Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A. Członkowska,et al.  The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse , 1999, Experimental Neurology.

[103]  F. Eusebi,et al.  CXC chemokines interleukin-8 (IL-8) and growth-related gene product α (GROα) modulate Purkinje neuron activity in mouse cerebellum , 1998, Journal of Neuroimmunology.

[104]  R. Miller,et al.  Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[105]  R. Ganju,et al.  The α-Chemokine, Stromal Cell-derived Factor-1α, Binds to the Transmembrane G-protein-coupled CXCR-4 Receptor and Activates Multiple Signal Transduction Pathways* , 1998, The Journal of Biological Chemistry.

[106]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.

[107]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[108]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[109]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[110]  S. Arya,et al.  Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells , 1995, Science.

[111]  W. Gorospe,et al.  Role of the Cytokines in the Neuroendocrine-Immune System Axis , 1995, Frontiers in Neuroendocrinology.

[112]  G. Fillion,et al.  Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. , 1993, Neuroendocrinology.

[113]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[114]  A. Beaudet,et al.  Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and the interfascicular nucleus , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[115]  C. Saper,et al.  Interleukin-1 immunoreactive innervation of the human hypothalamus. , 1988, Science.

[116]  E. Appella,et al.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[117]  W. Rostène.  Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (vip) , 1984, Progress in Neurobiology.

[118]  L. McCoy,et al.  Primary structure of human platelet factor 4. , 1977, Thrombosis research.

[119]  O. Meucci.  Chemokine Receptors and NeuroAIDS , 2010 .

[120]  S. Przedborski.  Inflammation and Parkinson's disease pathogenesis , 2010, Movement disorders : official journal of the Movement Disorder Society.

[121]  M. Struthers,et al.  CCR2 antagonists. , 2010, Current topics in medicinal chemistry.

[122]  J. Harrison,et al.  The chemokine receptors , 2007 .

[123]  Z. Brown,et al.  Chemokine Receptors , 2006, Treatments in respiratory medicine.

[124]  C. Yiannoutsos,et al.  SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. , 2003, Journal of neuropathology and experimental neurology.

[125]  F. Eusebi,et al.  CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. , 1998, Journal of neuroimmunology.

[126]  S. Arya,et al.  Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. , 1995, Science.

[127]  E. Ban,et al.  Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. , 1992, Cytokine.

[128]  J. Blalock.  A molecular basis for bidirectional communication between the immune and neuroendocrine systems. , 1989, Physiological reviews.

[129]  C. Kordon,et al.  Integrated communication between the nervous, endocrine and immune systems. , 1989, Hormone research.

[130]  L. McCoy,et al.  Purification and characterization of human and bovine platelet factor 4. , 1977, Preparative biochemistry.